268 related articles for article (PubMed ID: 19432545)
1. G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection.
Noguchi C; Imamura M; Tsuge M; Hiraga N; Mori N; Miki D; Kimura T; Takahashi S; Fujimoto Y; Ochi H; Abe H; Maekawa T; Tateno C; Yoshizato K; Chayama K
J Infect Dis; 2009 Jun; 199(11):1599-607. PubMed ID: 19432545
[TBL] [Abstract][Full Text] [Related]
2. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
3. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation.
Liu CJ; Chen PJ; Lai MY; Kao JH; Chang CF; Wu HL; Shau WY; Chen DS
Gastroenterology; 2003 Jan; 124(1):80-90. PubMed ID: 12512032
[TBL] [Abstract][Full Text] [Related]
4. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
Ying RS; Zhu C; Fan XG; Li N; Tian XF; Liu HB; Zhang BX
Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA.
Rosmorduc O; Petit MA; Pol S; Capel F; Bortolotti F; Berthelot P; Brechot C; Kremsdorf D
Hepatology; 1995 Jul; 22(1):10-9. PubMed ID: 7601398
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
Kumar M; Chauhan R; Gupta N; Hissar S; Sakhuja P; Sarin SK
Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy.
Crane M; Oliver B; Matthews G; Avihingsanon A; Ubolyam S; Markovska V; Chang JJ; Dore GJ; Price P; Visvanathan K; French M; Ruxrungtham K; Lewin SR
J Infect Dis; 2009 Apr; 199(7):974-81. PubMed ID: 19231993
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
10. [Quantitative detection of serum hepatitis B wild type virus and the precore mutant genomes using competitive polymerase chain reaction in patients with HBeAg(-) chronic hepatitis B].
Zhang X; Xiong S; Lu Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Mar; 11(1):33-6. PubMed ID: 15619900
[TBL] [Abstract][Full Text] [Related]
11. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis.
Märschenz S; Endres AS; Brinckmann A; Heise T; Kristiansen G; Nürnberg P; Krüger DH; Günther S; Meisel H
Gastroenterology; 2006 Sep; 131(3):765-80. PubMed ID: 16952546
[TBL] [Abstract][Full Text] [Related]
13. G to A hypermutation of hepatitis B virus.
Noguchi C; Ishino H; Tsuge M; Fujimoto Y; Imamura M; Takahashi S; Chayama K
Hepatology; 2005 Mar; 41(3):626-33. PubMed ID: 15726649
[TBL] [Abstract][Full Text] [Related]
14. Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B.
von Freyend MJ; Untergasser A; Arzberger S; Oberwinkler H; Drebber U; Schirmacher P; Protzer U
J Viral Hepat; 2011 Mar; 18(3):216-26. PubMed ID: 20367794
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
El-Zayadi AR; Badran HM; Saied A; Shawky S; Attia Mel-D; Zalata K
Am J Gastroenterol; 2009 Apr; 104(4):906-11. PubMed ID: 19293791
[TBL] [Abstract][Full Text] [Related]
16. Expression of CXC chemokine IP-10 in patients with chronic hepatitis B.
Wang J; Zhao JH; Wang PP; Xiang GJ
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):45-50. PubMed ID: 18234638
[TBL] [Abstract][Full Text] [Related]
17. [Occult hepatitis B virus infection in chronic viral hepatitis patients with non-A to E hepatitis virus infection].
Shang QH; Yu JG; Xu CZ; An Y; Liu FY; Sun SC; Zhang GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):440-2. PubMed ID: 19544639
[TBL] [Abstract][Full Text] [Related]
18. Changes in hepatitis B virus DNA levels with acute HIV infection.
Thio CL; Netski DM; Myung J; Seaberg EC; Thomas DL
Clin Infect Dis; 2004 Apr; 38(7):1024-9. PubMed ID: 15034837
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
20. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
Takkenberg RB; Zaaijer HL; Molenkamp R; Menting S; Terpstra V; Weegink CJ; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
J Med Virol; 2009 Jun; 81(6):988-95. PubMed ID: 19382261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
